U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Stage IIIC Cervical Cancer FIGO 2018

MedGen UID:
1702930
•Concept ID:
C5206451
•
Neoplastic Process
Synonym: Stage IIIC Cervical Carcinoma FIGO 2018

Definition

Cervical carcinoma with involvement of pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent (with r and p notations). (FIGO 2018) [from NCI]

Professional guidelines

PubMed

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y, Zhang G, Li Z, Chen B, Zhao H, Yang Y, Wang L, Yao J, Chen X, Huang Y, Lang J, Liu P, Chen C
Cancer Med 2023 Oct;12(19):19617-19632. Epub 2023 Sep 28 doi: 10.1002/cam4.6586. PMID: 37768092Free PMC Article
Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y, Li Z, Kang S, Yang Y, Ling B, Wang L, Yao J, Li P, Wang X, Gong S, Fan H, Kong Y, Cao Y, Lang J, Liu P, Chen C
BMC Cancer 2023 May 9;23(1):421. doi: 10.1186/s12885-023-10801-w. PMID: 37161372Free PMC Article

Recent clinical studies

Etiology

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y, Zhang G, Li Z, Chen B, Zhao H, Yang Y, Wang L, Yao J, Chen X, Huang Y, Lang J, Liu P, Chen C
Cancer Med 2023 Oct;12(19):19617-19632. Epub 2023 Sep 28 doi: 10.1002/cam4.6586. PMID: 37768092Free PMC Article
Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y, Li Z, Kang S, Yang Y, Ling B, Wang L, Yao J, Li P, Wang X, Gong S, Fan H, Kong Y, Cao Y, Lang J, Liu P, Chen C
BMC Cancer 2023 May 9;23(1):421. doi: 10.1186/s12885-023-10801-w. PMID: 37161372Free PMC Article
Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Holm J, Gerke O, Vilstrup MH, Spasojevic D, Sponholtz SE, Jochumsen KM, Thomassen A, Hildebrandt MG, Jensen PT
Gynecol Oncol 2022 Nov;167(2):152-158. Epub 2022 Sep 28 doi: 10.1016/j.ygyno.2022.09.021. PMID: 36182533
Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A, Høgdall C, Schnack T
Gynecol Oncol 2022 Jun;165(3):506-513. Epub 2022 Mar 26 doi: 10.1016/j.ygyno.2022.02.017. PMID: 35346512
Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G, Vinti D, Murgia F, Chiappa V, Leone Roberti Maggiore U, Martinelli F, Ditto A, Raspagliesi F
Int J Gynecol Cancer 2019 Nov;29(9):1355-1360. Epub 2019 Aug 17 doi: 10.1136/ijgc-2019-000669. PMID: 31422352

Diagnosis

Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A, Høgdall C, Schnack T
Gynecol Oncol 2022 Jun;165(3):506-513. Epub 2022 Mar 26 doi: 10.1016/j.ygyno.2022.02.017. PMID: 35346512
Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN, Dejean R, Beauchemin MC, Samouëlian V, Cormier B, Bacha OM, Warkus T, Barkati M
Gynecol Oncol 2021 Aug;162(2):277-283. Epub 2021 May 29 doi: 10.1016/j.ygyno.2021.05.023. PMID: 34059350
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
Yang E, Huang S, Ran X, Huang Y, Li Z
BMC Cancer 2021 Feb 27;21(1):203. doi: 10.1186/s12885-021-07890-w. PMID: 33639874Free PMC Article
Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
Takahashi M, Sakai K, Iwasa N, Wada M, Hino M, Kurahashi T, Ueno M, Nakagawa H
J Obstet Gynaecol Res 2021 May;47(5):1871-1877. Epub 2021 Feb 21 doi: 10.1111/jog.14713. PMID: 33611822
Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G, Vinti D, Murgia F, Chiappa V, Leone Roberti Maggiore U, Martinelli F, Ditto A, Raspagliesi F
Int J Gynecol Cancer 2019 Nov;29(9):1355-1360. Epub 2019 Aug 17 doi: 10.1136/ijgc-2019-000669. PMID: 31422352

Prognosis

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y, Zhang G, Li Z, Chen B, Zhao H, Yang Y, Wang L, Yao J, Chen X, Huang Y, Lang J, Liu P, Chen C
Cancer Med 2023 Oct;12(19):19617-19632. Epub 2023 Sep 28 doi: 10.1002/cam4.6586. PMID: 37768092Free PMC Article
Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Holm J, Gerke O, Vilstrup MH, Spasojevic D, Sponholtz SE, Jochumsen KM, Thomassen A, Hildebrandt MG, Jensen PT
Gynecol Oncol 2022 Nov;167(2):152-158. Epub 2022 Sep 28 doi: 10.1016/j.ygyno.2022.09.021. PMID: 36182533
Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A, Høgdall C, Schnack T
Gynecol Oncol 2022 Jun;165(3):506-513. Epub 2022 Mar 26 doi: 10.1016/j.ygyno.2022.02.017. PMID: 35346512
Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
Qin F, Pang H, Yu T, Luo Y, Dong Y
Technol Cancer Res Treat 2022 Jan-Dec;21:15330338221086403. doi: 10.1177/15330338221086403. PMID: 35341413Free PMC Article
Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G, Vinti D, Murgia F, Chiappa V, Leone Roberti Maggiore U, Martinelli F, Ditto A, Raspagliesi F
Int J Gynecol Cancer 2019 Nov;29(9):1355-1360. Epub 2019 Aug 17 doi: 10.1136/ijgc-2019-000669. PMID: 31422352

Clinical prediction guides

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y, Zhang G, Li Z, Chen B, Zhao H, Yang Y, Wang L, Yao J, Chen X, Huang Y, Lang J, Liu P, Chen C
Cancer Med 2023 Oct;12(19):19617-19632. Epub 2023 Sep 28 doi: 10.1002/cam4.6586. PMID: 37768092Free PMC Article
Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A, Høgdall C, Schnack T
Gynecol Oncol 2022 Jun;165(3):506-513. Epub 2022 Mar 26 doi: 10.1016/j.ygyno.2022.02.017. PMID: 35346512
Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
Shin W, Ham TY, Park YR, Lim MC, Won YJ
Sci Rep 2021 Mar 26;11(1):6988. doi: 10.1038/s41598-021-86283-2. PMID: 33772044Free PMC Article
The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L, Zhang Q, Kong Y, Yang F, Zhou Y, Yu S, Wu M, Chen J, Zhang Y, Xiang Y
Gynecol Oncol 2020 Mar;156(3):676-681. Epub 2019 Dec 24 doi: 10.1016/j.ygyno.2019.12.022. PMID: 31882242
Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G, Vinti D, Murgia F, Chiappa V, Leone Roberti Maggiore U, Martinelli F, Ditto A, Raspagliesi F
Int J Gynecol Cancer 2019 Nov;29(9):1355-1360. Epub 2019 Aug 17 doi: 10.1136/ijgc-2019-000669. PMID: 31422352

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...